We read with interest the Platinum Opinion by Vickers et al [1] suggesting that the routine use of magnetic resonance imaging (MRI) for early detection of prostate cancer in patients with elevated serum prostate-specific antigen levels, as advised by the urological guidelines, are misguided and not justified by clinical trials evidence. Their arguments focus on the lack of oncological equivalence of cancers found via MRI-directed biopsies (MRDBs) against systematic 10–12-core biopsies (SBs). Furthermore, they comment on the lack of superiority of MRI approaches for detection of higher-grade (grade group [GG] ≥2) cancers.
Platinum ppinion counterview: the evidence base for the benefit of magnetic resonance imaging-directed prostate cancer diagnosis is sound / Padhani, A. R.; Villeirs, G.; Ahmed, H. U.; Panebianco, V.; Schoots, I. G.; Tempany, C. M. C.; Weinreb, J.; Barentsz, J. O.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 78:3(2020), pp. 307-309.
Titolo: | Platinum ppinion counterview: the evidence base for the benefit of magnetic resonance imaging-directed prostate cancer diagnosis is sound | |
Autori: | ||
Data di pubblicazione: | 2020 | |
Rivista: | ||
Citazione: | Platinum ppinion counterview: the evidence base for the benefit of magnetic resonance imaging-directed prostate cancer diagnosis is sound / Padhani, A. R.; Villeirs, G.; Ahmed, H. U.; Panebianco, V.; Schoots, I. G.; Tempany, C. M. C.; Weinreb, J.; Barentsz, J. O.. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 78:3(2020), pp. 307-309. | |
Handle: | http://hdl.handle.net/11573/1429872 | |
Appartiene alla tipologia: | 01a Articolo in rivista |
File allegati a questo prodotto
File | Note | Tipologia | Licenza | |
---|---|---|---|---|
Padhani_Platinum_2020.pdf | Versione editoriale (versione pubblicata con il layout dell'editore) | Tutti i diritti riservati (All rights reserved) | Administrator Richiedi una copia |